Explore our complete collection of sustainability articles. Use filters to find exactly what you're looking for.
Popular Topics
Active Filters:
Showing 12 of 74 articles
A rigorous look at the most persistent misconceptions about Microbiomes, soil health & ecosystems, with evidence-based corrections and practical implications for decision-makers.
A rigorous look at the most persistent misconceptions about Climate biotech: carbon-negative processes, with evidence-based corrections and practical implications for decision-makers.
Strategic analysis of value creation and capture in Climate biotech: carbon-negative processes, mapping where economic returns concentrate and which players are best positioned to benefit.
Comprehensive comparison of batch fermentation, continuous bioprocessing, and cell-free synthesis for commercial biomanufacturing. Continuous processes reduce production costs 20–40% at scale but require $10–50M more in automation infrastructure, while cell-free systems achieve 10x faster development cycles for high-value molecules under $1B annual market size.
Detailed cost and ROI analysis for conservation genetics programs including eDNA monitoring ($500–5,000 per site), whole-genome sequencing for endangered species ($10,000–50,000 per population), and assisted gene flow projects ($200K–2M per species). Genetic rescue programs show 3–10x ROI versus captive breeding alone based on population viability improvements.
Side-by-side evaluation of biological carbon removal approaches (engineered algae, enhanced weathering microbes, soil carbon biotech) versus chemical processes (DAC, mineral carbonation). Biological pathways offer costs of $50–150 per tonne CO₂ but face permanence challenges, while chemical routes achieve 1,000+ year storage at $250–600 per tonne.
End-to-end cost and ROI guide for biomanufacturing scale-up from bench to commercial production. A 200,000-liter fermentation facility typically requires $100–300M capex with 4–8 year payback, while COGS reduction of 30–60% is achievable between pilot (1,000 L) and commercial scale (200,000 L) through yield optimization and process intensification.
Detailed cost and ROI analysis for carbon-negative biotech ventures including engineered algae, methanotroph platforms, and microbial carbon mineralization. Early-stage companies require $5–30M in R&D before pilot deployment, with carbon credit revenues of $50–200 per tonne needed to reach breakeven within 7–12 years.
Global conservation genetics funding reached $2.1 billion in 2025, yet fewer than 8% of threatened species have genomic data sufficient for adaptive management. Genetic rescue programs have boosted population fitness by 20–150% in documented cases (Florida panther, Australian mountain pygmy possum), while restoration projects using genetically diverse seed sources show 30–45% higher survival rates. This data story maps funding flows, project success rates, and emerging genomic tool adoption across 190+ countries.
Environmental DNA (eDNA) sampling detects species presence from water or soil at $50–$200 per sample with 85–95% detection accuracy for target taxa, while metabarcoding captures broader community composition at $150–$500 per sample. Whole-genome sequencing reveals population structure and adaptive potential at $1,000–$5,000 per individual. This guide compares cost-effectiveness, taxonomic resolution, scalability, and decision-support value for restoration and monitoring programs.
Side-by-side evaluation of leading conservation genetics approaches for biodiversity monitoring and restoration. eDNA surveys detect species at 1/10th the cost of traditional field surveys, population genomics identifies adaptive potential across fragmented habitats, and gene drives offer 90%+ suppression of invasive species but face regulatory timelines of 5–15 years.
A practical primer on how soil and environmental microbiomes drive ecosystem health, carbon cycling, and agricultural productivity. Healthy soil microbiomes contain 10,000–50,000 bacterial species per gram and can sequester 0.5–1.5 tonnes of CO₂ per hectare annually, while microbial inoculant markets are projected to reach $14B by 2028.